News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Apr / 2026

April 2026
M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

« Mar

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Myelo 2026: Virtual Global Congress on Multiple Myeloma

Myelo 2026: Virtual Global Congress on Multiple Myeloma

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

Joshua Mason Takes on US Medical Head Role at AstraZeneca

Joshua Mason Takes on US Medical Head Role at AstraZeneca

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Top 5 Reviewers of 2025 for the Journal of Thoracic Oncology - IASLC

Top 5 Reviewers of 2025 for the Journal of Thoracic Oncology - IASLC

Alejandra Mendez and Liliana Vasquez: Advancing Childhood Cancer Survival Together in Latin America

Alejandra Mendez and Liliana Vasquez: Advancing Childhood Cancer Survival Together in Latin America

Tania Small: Stand With Science, Because When Science Stalls, Patients Suffer

ERBB2-Amplified mCRC

Dec 17, 2025 5:49 am

New Paper Alert

New GI Paper Alert: Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

New GI Paper Alert: Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

Headlines

Trump’s 2027 Budget Targets Major Cuts to Science Funding

Helen McCrory’s Breast Cancer Story: From Harry Potter to Peaky Blinders and a Private Battle

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

A New Open Access Journal "Adolescent and Young Adult Cancer" by ACS

8-Year-Old Dances His Way Out After Beating Leukemia

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Breast Cancer Global fight against cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC MD Anderson Cancer Center cancer treatment cancer awareness Research colorectal cancer ASCO24 Childhood Cancer clinical trials AACR prostate cancer FDA UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Robert Orlowski Myeloma NCI Pancreatic Cancer Myeloma Paper of the Day National Cancer Institute Vivek Subbiah American Society of Clinical Oncology Paolo Tarantino AI radiation oncology healthcare cervical cancer IASLC WHO Memorial Sloan Kettering Cancer Center ASCO25 multiple myeloma Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}